Abbott's FreeStyle Libre 2 and 3 are the first and only patient-applied continuous glucose monitoring (CGM) systems to be ...

Adjusted earnings per share amounted to EUR 0.35 in the third quarter of 2024 (PY: EUR 0.43). Free cash flow increased by EUR 9.6 million to EUR 17.3 million compared to the prior year. Net debt ...

The US Food and Drug Administration has okayed removal of the contraindication for use during CT and MRI under certain ...

The following is a summary of “Efficacy of continuous glucose monitoring in people living with diabetes and end stage kidney ...

Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for ...

CMA CGM Group is strengthening its presence in Morocco through a new joint venture with Marsa Maroc to operate half of the ...

Dexcom announced today that, following the conclusion of the third quarter, it submitted its 15-day G7 CGM to the FDA.

CMA CGM is stepping up port investments in the strategically important western Mediterranean with Moroccan terminal operator ...

CMA CGM Group, in collaboration with Singapore’s Eastern Pacific Shipping (EPS), has marked a milestone in maritime ...

ASTANA, Kazakhstan, November 6. In a significant meeting, President Kassym-Jomart Tokayev welcomed Rodolphe Saadé, President ...

Medtronic is modestly undervalued based on DCF analysis, but slow revenue growth limits upside potential. Read why I ...

Beta Bionics announced today that it launched the integration of the iLet bionic pancreas with the Abbott (NYSE:ABT) ...